Science & Enterprise subscription

Follow us on Twitter

  • An engineering group found a way to adapt a CPAP machine into a mechanical ventilator, a device for people needing… https://t.co/tJcdzaLspJ
    about 17 hours ago
  • New post on Science and Enterprise: Univ. Engineers Convert CPAP into Ventilator https://t.co/atwZ62PHU0 #Science #Business
    about 17 hours ago
  • A biotechnology company specializing in infectious diseases is developing a vaccine to protect against Covid-19 inf… https://t.co/RT5znygGYm
    about 24 hours ago
  • New post on Science and Enterprise: Covid-19 Vaccine in Development, Trial Planned https://t.co/CxTssHGlFw #Science #Business
    about 24 hours ago
  • A group of Canadian academic labs and hospitals will begin a clinical trial testing antibodies from recovered Covid… https://t.co/BsfaYEhTGM
    about 2 days ago

Please share Science & Enterprise

Trial Shows Rare Disease Drug Treats Covid-19 Patients

Covid-19 illustration

Results from a clinical trial show a drug approved for a rare lymph node disease can stabilize or improve the condition of many people with severe Covid-19 complications. . . . → Read More: Trial Shows Rare Disease Drug Treats Covid-19 Patients

Phone App Tracking Covid-19 Symptom Reports

Phone user

A smartphone app is collecting individual reports about Covid-19 symptoms and other health conditions to provide earlier warnings of outbreaks to health authorities. . . . → Read More: Phone App Tracking Covid-19 Symptom Reports

Start-Up Licenses Immunotherapies in $880M Deal

Human T-cell

A new biotechnology enterprise creating treatments that alter chemical functions in immune cells agreed to license its technology to a pharmaceutical company. . . . → Read More: Start-Up Licenses Immunotherapies in $880M Deal

Business-Foundation Alliance Funds Covid-19 Treatments

Coronavirus graphic

Two foundations and a credit card company are providing seed money for development and manufacture of treatments for the novel coronavirus or Covid-19 pandemic. . . . → Read More: Business-Foundation Alliance Funds Covid-19 Treatments

Skin Cancer Apps Shown Misleading, Unreliable

Phone photo

A review of smartphone apps that photograph and purport to analyze skin conditions for signs of cancer shows the apps are unreliable in detecting cancer. . . . → Read More: Skin Cancer Apps Shown Misleading, Unreliable

Infographic – Mediocre ClinicalTrials.gov Report Rates

Chart: Clinical trials report

New data show most sponsors of clinical trials are not reporting their results on time to a U.S. government web site as required by law. . . . → Read More: Infographic – Mediocre ClinicalTrials.gov Report Rates

Vaccine Developer Gains $11M in Early Funds

Baby with microcephaly

A company designing vaccines delivered with a microneedle patch to prevent infectious diseases is raising $11 million in its first venture funding round. . . . → Read More: Vaccine Developer Gains $11M in Early Funds

Guidelines Proposed for Complex Clinical Trials

Chemotherapy vials

A working group published guidelines for conducting clinical trials that simultaneously test multiple cancer treatments and can change course over time. . . . → Read More: Guidelines Proposed for Complex Clinical Trials

Commentary – New Models Needed for Antibiotic Resistance

MRSA bacteria

Many parts of a new model for fighting antibiotic resistance are in development, and the pieces still need to be assembled, but the outline of a precision-medicine rather than mass-produced drug model is beginning to emerge. . . . → Read More: Commentary – New Models Needed for Antibiotic Resistance

Climate Action Cost Accounting Standard Proposed

Climate change skyline

A new paper proposes an accounting standard that would require private companies to spell out their costs of meeting net-zero greenhouse gas emissions. . . . → Read More: Climate Action Cost Accounting Standard Proposed